openPR Logo
Press release

Bacterial Conjunctivitis Drug Market – Global Industry Insights and Opportunity Analysis 2025

10-06-2017 03:35 PM CET | Health & Medicine

Press release from: Pharmaceutical Report By CMI

Bacterial Conjunctivitis Drug Market – Global Industry

Bacterial conjunctivitis is inflammation of the outermost layer of the eye and inner area of the eyelid. Bacterial conjunctivitis symptoms include swelling, watery eyes, and redness. Bacteria responsible for conjunctivitis include staphylococci, haemophilus, Chlamydia trachomatis, and streptococci. Children and geriatric population are highly prone to bacterial conjunctivitis, however, it affects people of all age groups. The increasing cases of bacterial conjunctivitis demand efficient medication, which supports the growth of bacterial conjunctivitis drugs market. Bacterial conjunctivitis spreads because of poor hygiene, immune compromise, ocular diseases such as dry eye, blepharitis, and contaminated cosmetics. It can be prevented by maintaining proper hygiene and also hand wash reduces the chances of bacterial conjunctivitis.

Bacterial Conjunctivitis Drug Market Taxonomy

By Disease Type;

-Acute Bacterial Conjunctivitis
-Chronic Bacterial Conjunctivitis

By Treatment Type;

-Fluoroquinolones
-Macrolides
-Aminoglycosides

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/714

By Route of Administration;

-Topical
-Oral
-Intravitreal

By End User;

-Hospitals
-Clinics

Increasing incidences of bacterial conjunctivitis and availability of generic drugs to fuel the market growth

The spread of ophthalmic bacterial infection increased the demand for antibacterial drugs for its treatment. According to National Center for Biotechnology Information (NCBI) 2013 report, in the U.S., there were around 6 million people affected by conjunctivitis. Bacterial conjunctivitis takes around a week to get completely cured and fluoroquinolones are the most preferred drug for the treatment of bacterial conjunctivitis. There are certain drugs in the market that are patented and their patents about to expire, this, in turn, is expected to increase the market for generic drugs, which are of less price as well. Moxeza, vigamox, besivance, and zymaxid are some of the most successful patented drugs about to expire. After patent expiry, these drugs lose their exclusivity, which leads to increase in use of generic drugs. The development of multi-drug resistant variants is expected to fuel the growth of bacterial conjunctivitis drug market. The unnecessary use of antibiotics causes the disease causing bacteria to chemically evolve themselves and become resistant to drugs. This, in turn, may lead to the prescription of strong medication, which includes corticosteroids and high dose of antibiotics.

Rising occurrence of bacterial conjunctivitis demands safe and efficient drugs, which leads to the development of new drugs, such as vancomycin ophthalmic ointment, that are in the clinical trial pipeline and few are pending for approval. Some of the major challenges faced by bacterial conjunctivitis drug market are patent expiry and awareness about the disease that it cures itself in a week. However, the shift in preference toward herbal treatment from pharmacological treatment is expected to create new opportunities in the bacterial conjunctivitis drug market. Moreover, herbal formulation based drugs are widely accepted, which in turn leads to the development and investment in herbal products for the treatment of bacterial conjunctivitis. The aforementioned scenario is expected to support the growth of bacterial conjunctivitis drugs market over the forecast period.

Developed regions support the growth of bacterial conjunctivitis drug market

On the basis of geography, bacterial conjunctivitis drug market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominates the bacterial conjunctivitis drugs market due to the presence of advanced healthcare facilities and reimbursement policies. Europe is the second largest region followed by Asia Pacific. Asia Pacific is expected to witness moderate growth over the forecast period owing to the high awareness about the disease among public and high per capita income.

Click here to know more about this report: https://www.coherentmarketinsights.com/ongoing-insight/bacterial-conjunctivitis-drug-market-714

Key Players in the Bacterial Conjunctivitis Drug Market

Some of the key players contributing to the bacterial conjunctivitis drug market growth are, Pfizer Inc., Novartis AG, F. Hoffmann-La Roche, Bayer Healthcare, Valeant Pharmaceutical International Inc., Perrigo Company Plc, Akorn Inc., Santen Pharmaceutical Co. Ltd., and Allergan Plc. For increasing market share, the companies adopt various strategies such as mergers and acquisitions. For instance, in 2015, Shire acquired Foresight Biotherapeutics to increase its ophthalmic product pipeline.

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bacterial Conjunctivitis Drug Market – Global Industry Insights and Opportunity Analysis 2025 here

News-ID: 760779 • Views: 300

More Releases from Pharmaceutical Report By CMI

Rising prevalence of diabetes is a major factor driving growth of the diabetic f …
Diabetic foot ulcers is a common condition in diabetic patients. It is a disabling disorder, which might lead to amputation of the leg. Mortality due to diabetic foot ulcers is high and chances of recurrence of cured foot ulcers is also high and this in turn leads to increasing demand for proper treatment of diabetic foot ulcers. Diabetic foot ulcer is caused due to neuropathic and vascular changes in the
Glucagon-Like Peptide-1 (Glp-1) Analogs Market Global Industry Insights, Trends, …
Glucagon-like peptide-1 (GLP-1) analogs also known as incretin mimetics are class of drugs indicated for type-2 diabetes mellitus to lower the blood sugar level. GLP-1 analogs prevents the breakdown of GLP-1, thereby enhancing the glucose depended insulin release, suppresses the glucagon release (which reduces hepatic glucose output), and reduces gastric emptying rate (resulting in weight loss from reduced appetite). GLP-1 analogs do not cause hypoglycemia like other class of anti-diabetic
Multiple Sclerosis Therapeutics Market to Surpass US$ 24.4 Billion by 2025
Increasing prevalence of multiple sclerosis to augment market growth Multiple sclerosis is a widespread disabling neurological condition, mostly diagnosed in people in the age group 20–50 years. According to the Multiple Sclerosis Foundation, 2017, this autoimmune condition affects 2.5 million people with the global incidence of around 7 cases per 100,000 people per year. The study also states that prevalence rates varies between ethnic and geographical latitudes, ranging from 50 to
Diabetic Foot Ulcers Treatment Market to Surpass US$ 9.49 Billion Threshold by 2 …
Diabetic foot ulcers is a common condition in diabetic patients. It is a disabling disorder, which might lead to amputation of the leg. Mortality due to diabetic foot ulcers is high and chances of recurrence of cured foot ulcers is also high and this in turn leads to increasing demand for proper treatment of diabetic foot ulcers. Diabetic foot ulcer is caused due to neuropathic and vascular changes in the

All 5 Releases


More Releases for Bacteria

Bacteria as CO2 recycling powerhouse
E. coli can live and feed on formate & methanol: Scientists from the Max Planck Institute (Germany) have reached a significant breakthrough presented in their recent Nature Chemical Biology publication. Their research for EU project eForFuel has redesigned the model biotechnological bacteria Escherichia coli (E. coli) to live and feed on methanol and formate: a possibility that serves as a stepping stone towards future endeavors aiming at recycling CO2 into various
Bacteria Sourced Microbial Lipase Market
https://www.qandqmarketresearch.com/reports/7482906/bacteria-sourced-microbial-lipase-market-55 The global Bacteria Sourced Microbial Lipase market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 20192025. The objectives of this study are to define, segment, and project the size of the Bacteria Sourced Microbial Lipase market based on company, product type, end user and key regions. This report studies the global market size of Bacteria Sourced
Global Beneficial Bacteria Market Application, Industry Analysis & Forecast by 2 …
The market for chemical industry is growing with the expansion of this Industry Sector Worldwide. Market Research Hub (MRH) has added a new report titled “Global Beneficial Bacteria Market Size, Trends, Revenue and Future Scenario Forecast Until 2025”which offer details about the current trends and analysis, as well as scope for the near future. This research study also covers information about the production, consumption and market share based on different
Anti-bacteria Coating Market: Global Industry Size, Share, Growth, Forecasts
Latest industry research report on: Global Anti-bacteria Coating Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts. In this report, the global Anti-bacteria Coating market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. In addition, drivers, restraints and opportunities, competitive landscape have also been
03-27-2017 | Energy & Environment
PRD
Bacteria, deadwood and climate changeT
With the support of the Austrian Science Fund FWF, an international group of researchers is investigating to what extent the forest floor serves as a carbon sink and how bacteria and fungi interact in this context. The researchers have found deadwood to be populated by a great diversity of life. "The wealth of microorganisms we found in deadwood was astounding", says the microbiologist Judith Ascher-Jenull. It has long been known
Europe Bacteria Colony Counter Market Report 2017
This report studies sales (consumption) of Bacteria Colony Counter in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering AID Boeckel Interscience Molecular Devices Request Sample Report: http://www.reportbazzar.com/request-sample/?pid=825762&ptitle=Europe+Bacteria+Colony+Counter+Market+Report+2017&req=Sample S.M. Scientific Instruments Stuart Equipment Suntex Instruments Synbiosis UVP WTW Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate